Sonoma Pharmaceuticals (SNOA) Inventory Average (2011 - 2025)

Sonoma Pharmaceuticals' Inventory Average history runs 15 years deep, the most recent figure standing at $4.0 million for Q4 2025.

• In Q4 2025, Inventory Average rose 33.08% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (up 33.08% YoY), while the FY2025 annual figure was $3.1 million, up 6.04% from the prior year.
• Inventory Average was $4.0 million for Q4 2025 at Sonoma Pharmaceuticals, up from $3.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $4.0 million in Q4 2025 to a low of $2.6 million in Q3 2021.
• Historically, Inventory Average has averaged $2.9 million across 5 years, with a median of $2.8 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Inventory Average tumbled 35.39% in 2021, then surged 40.87% in 2025.
• A 5-year view of Inventory Average shows it stood at $2.7 million in 2021, then rose by 9.57% to $2.9 million in 2022, then declined by 6.91% to $2.7 million in 2023, then increased by 9.36% to $3.0 million in 2024, then soared by 33.08% to $4.0 million in 2025.
• The last three Inventory Average figures came in at $4.0 million (Q4 2025), $3.9 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.